Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 657

1.

Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian model.

Hoskins P, Eccleston A, Hurry M, Dyer M.

Gynecol Oncol. 2019 Jan 28. pii: S0090-8258(19)30061-7. doi: 10.1016/j.ygyno.2019.01.018. [Epub ahead of print]

PMID:
30704745
2.

Bioabsorption and effectiveness of long-lasting permethrin-treated uniforms over three months among North Carolina outdoor workers.

Sullivan KM, Poffley A, Funkhouser S, Driver J, Ross J, Ospina M, Calafat AM, Beard CB, White A, Balanay JA, Richards S, Dyer M, Mather TN, Meshnick S.

Parasit Vectors. 2019 Jan 23;12(1):52. doi: 10.1186/s13071-019-3314-1.

3.

The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment.

Brady SW, Ma X, Bahrami A, Satas G, Wu G, Newman S, Rusch M, Putnam DK, Mulder HL, Yergeau DA, Edmonson MN, Easton J, Alexandrov LB, Chen X, Mardis ER, Wilson RK, Downing JR, Pappo AS, Raphael BJ, Dyer MA, Zhang J.

Mol Cancer Res. 2019 Jan 16. doi: 10.1158/1541-7786.MCR-18-0620. [Epub ahead of print]

PMID:
30651371
4.

Optimal sequencing of chemoradiotherapy for locally advanced laryngeal cancer.

Shah NK, Qureshi MM, Dyer MA, Patel SA, Kim K, Everett PC, Grillone GA, Jalisi SM, Truong MT.

Laryngoscope. 2019 Jan 9. doi: 10.1002/lary.27771. [Epub ahead of print]

PMID:
30628077
5.

Chemical control of structure and guest uptake by a conformationally mobile porous material.

Katsoulidis AP, Antypov D, Whitehead GFS, Carrington EJ, Adams DJ, Berry NG, Darling GR, Dyer MS, Rosseinsky MJ.

Nature. 2019 Jan;565(7738):213-217. doi: 10.1038/s41586-018-0820-9. Epub 2019 Jan 9.

PMID:
30626943
6.

Genome-wide discovery of somatic coding and non-coding mutations in pediatric endemic and sporadic Burkitt lymphoma.

Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB, Allen H, Ayers LW, Bethony JM, Bhatia K, Bowen J, Casper C, Choi JK, Culibrk L, Davidsen TM, Dyer MA, Gastier-Foster JM, Gesuwan P, Greiner TC, Gross TG, Hanf B, Harris NL, He Y, Irvin JD, Jaffe ES, Jones SJM, Kerchan P, Knoetze N, Leal FE, Lichtenberg TM, Ma Y, Martin JP, Martin MR, Mbulaiteye SM, Mullighan CG, Mungall AJ, Namirembe C, Novik K, Noy A, Ogwang MD, Omoding A, Orem J, Reynolds SJ, Rushton CK, Sandlund JT, Schmitz R, Taylor C, Wilson WH, Wright GW, Zhao EY, Marra MA, Morin RD, Staudt LM.

Blood. 2019 Jan 7. pii: blood-2018-09-871418. doi: 10.1182/blood-2018-09-871418. [Epub ahead of print]

PMID:
30617194
7.

Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology.

Went M, Sud A, Speedy H, Sunter NJ, Försti A, Law PJ, Johnson DC, Mirabella F, Holroyd A, Li N, Orlando G, Weinhold N, van Duin M, Chen B, Mitchell JS, Mansouri L, Juliusson G, Smedby KE, Jayne S, Majid A, Dearden C, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Rosenquist R, Kuiper R, Stephens OW, Bertsch U, Broderick P, Einsele H, Gregory WM, Hillengass J, Hoffmann P, Jackson GH, Jöckel KH, Nickel J, Nöthen MM, da Silva Filho MI, Thomsen H, Walker BA, Broyl A, Davies FE, Hansson M, Goldschmidt H, Dyer MJS, Kaiser M, Sonneveld P, Morgan GJ, Hemminki K, Nilsson B, Catovsky D, Allan JM, Houlston RS.

Blood Cancer J. 2018 Dec 21;9(1):1. doi: 10.1038/s41408-018-0162-8.

8.

Evaluation of drug information resources for drug-ethanol and drug-tobacco interactions.

Beckett RD, Stump CD, Dyer MA.

J Med Libr Assoc. 2019 Jan;107(1):62-71. doi: 10.5195/jmla.2019.549. Epub 2019 Jan 1.

9.

Kinetics of T-cell subset reconstitution following treatment with bendamustine and rituximab for low-grade lymphoproliferative disease: a population-based analysis.

Martínez-Calle N, Hartley S, Ahearne M, Kasenda B, Beech A, Knight H, Balotis C, Kennedy B, Wagner S, Dyer MJS, Smith D, McMillan AK, Miall F, Bishton M, Fox CP.

Br J Haematol. 2018 Dec 13. doi: 10.1111/bjh.15722. [Epub ahead of print]

PMID:
30548597
10.

Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in haematological malignancies.

Al-Zebeeby A, Vogler M, Milani M, Richards C, Alotibi A, Greaves G, Dyer MJS, Cohen GM, Varadarajan S.

Haematologica. 2018 Nov 22. pii: haematol.2018.204701. doi: 10.3324/haematol.2018.204701. [Epub ahead of print]

11.

Structure determination and crystal chemistry of large repeat mixed-layer hexaferrites.

Delacotte C, Whitehead GFS, Pitcher MJ, Robertson CM, Sharp PM, Dyer MS, Alaria J, Claridge JB, Darling GR, Allan DR, Winter G, Rosseinsky MJ.

IUCrJ. 2018 Sep 12;5(Pt 6):681-698. doi: 10.1107/S2052252518011351. eCollection 2018 Nov 1.

12.

Combinatorial screening using orthotopic patient derived xenograft-expanded early phase cultures of osteosarcoma identify novel therapeutic drug combinations.

Loh AHP, Stewart E, Bradley CL, Chen X, Daryani V, Stewart CF, Calabrese C, Funk A, Miller G, Karlstrom A, Krafcik F, Goshorn DR, Vogel P, Bahrami A, Shelat A, Dyer MA.

Cancer Lett. 2019 Feb 1;442:262-270. doi: 10.1016/j.canlet.2018.10.033. Epub 2018 Nov 3.

PMID:
30395907
13.

CUDC-907 blocks multiple pro-survival signals and abrogates microenvironment protection in CLL.

Chen Y, Peubez C, Smith V, Xiong S, Kocsis-Fodor G, Kennedy B, Wagner S, Balotis C, Jayne S, Dyer MJS, Macip S.

J Cell Mol Med. 2019 Jan;23(1):340-348. doi: 10.1111/jcmm.13935. Epub 2018 Oct 24.

14.

DNA methylation profiling identifies candidate genes for the pathogenesis of hepatosplenic T-cell lymphoma.

Bergmann AK, Fataccioli V, Castellano G, Martin-Garcia N, Pelletier L, Ammerpohl O, Bergmann J, Bhat J, Carrillo-de Santa Pau E, Martín-Subero JI, Moffitt AB, Valencia A, Oberg HH, Wesch D, Jayne S, Dyer MJS, Kabelitz D, Gaulard P, Siebert R.

Haematologica. 2018 Oct 18. pii: haematol.2018.196196. doi: 10.3324/haematol.2018.196196. [Epub ahead of print]

15.

Structure searching methods: general discussion.

Addicoat M, Adjiman CS, Arhangelskis M, Beran GJO, Brandenburg JG, Braun DE, Burger V, Burow A, Collins C, Cooper A, Day GM, Deringer VL, Dyer MS, Hare A, Jelfs KE, Keupp J, Konstantinopoulos S, Li Y, Ma Y, Marom N, McKay D, Mellot-Draznieks C, Mohamed S, Neumann M, Nilsson Lill S, Nyman J, Oganov AR, Price SL, Reutzel-Edens S, Ruggiero M, Sastre G, Schmid R, Schmidt J, Schön JC, Spackman P, Tsuzuki S, Woodley SM, Yang S, Zhu Q.

Faraday Discuss. 2018 Oct 26;211(0):133-180. doi: 10.1039/c8fd90030b. No abstract available.

PMID:
30307457
16.

Applications of crystal structure prediction - inorganic and network structures: general discussion.

Burger V, Claeyssens F, Davies DW, Day GM, Dyer MS, Hare A, Li Y, Mellot-Draznieks C, Mitchell JBO, Mohamed S, Oganov AR, Price SL, Ruggiero M, Ryder MR, Sastre G, Schön JC, Spackman P, Woodley SM, Zhu Q.

Faraday Discuss. 2018 Oct 26;211(0):613-642. doi: 10.1039/c8fd90034e. No abstract available.

PMID:
30298165
17.

Definitive treatment patterns and survival in stage II non-small cell lung cancer.

Yan SX, Qureshi MM, Suzuki K, Dyer M, Truong MT, Litle V, Mak KS.

Lung Cancer. 2018 Oct;124:135-142. doi: 10.1016/j.lungcan.2018.07.035. Epub 2018 Jul 24.

PMID:
30268452
18.

Bi2+2 nO2+2 nCu2-δSe2+ n-δXδ (X = Cl, Br): A Three-Anion Homologous Series.

Gibson QD, Dyer MS, Robertson C, Delacotte C, Manning TD, Pitcher MJ, Daniels LM, Zanella M, Alaria J, Claridge JB, Rosseinsky MJ.

Inorg Chem. 2018 Oct 15;57(20):12489-12500. doi: 10.1021/acs.inorgchem.8b01126. Epub 2018 Sep 26.

PMID:
30256106
19.

ADAMTS13: origins, applications, and prospects.

Plautz WE, Raval JS, Dyer MR, Rollins-Raval MA, Zuckerbraun BS, Neal MD.

Transfusion. 2018 Oct;58(10):2453-2462. doi: 10.1111/trf.14804. Epub 2018 Sep 12. Review.

PMID:
30208220
20.

Computational Prediction and Experimental Realization of p-Type Carriers in the Wide-Band-Gap Oxide SrZn1- xLi xO2.

Tzitzeklis CA, Gupta JK, Dyer MS, Manning TD, Pitcher MJ, Niu HJ, Savvin S, Alaria J, Darling GR, Claridge JB, Rosseinsky MJ.

Inorg Chem. 2018 Oct 1;57(19):11874-11883. doi: 10.1021/acs.inorgchem.8b00697. Epub 2018 Sep 10.

PMID:
30198714
21.

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy.

Eyre TA, Walter HS, Iyengar S, Follows G, Cross M, Fox CP, Hodson A, Coats J, Narat S, Morley N, Dyer MJS, Collins GP.

Haematologica. 2019 Feb;104(2):e68-e71. doi: 10.3324/haematol.2018.198812. Epub 2018 Sep 6. No abstract available.

22.

Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses.

Stewart E, McEvoy J, Wang H, Chen X, Honnell V, Ocarz M, Gordon B, Dapper J, Blankenship K, Yang Y, Li Y, Shaw TI, Cho JH, Wang X, Xu B, Gupta P, Fan Y, Liu Y, Rusch M, Griffiths L, Jeon J, Freeman BB 3rd, Clay MR, Pappo A, Easton J, Shurtleff S, Shelat A, Zhou X, Boggs K, Mulder H, Yergeau D, Bahrami A, Mardis ER, Wilson RK, Zhang J, Peng J, Downing JR, Dyer MA; St. Jude Children's Research Hospital – Washington University Pediatric Cancer Genome Project.

Cancer Cell. 2018 Sep 10;34(3):411-426.e19. doi: 10.1016/j.ccell.2018.07.012. Epub 2018 Aug 23.

PMID:
30146332
23.

Heme Oxygenase-2 Localizes to Mitochondria and Regulates Hypoxic Responses in Hepatocytes.

Waltz PK, Kautza B, Luciano J, Dyer M, Stolz DB, Loughran P, Neal MD, Sperry JL, Rosengart MR, Zuckerbraun BS.

Oxid Med Cell Longev. 2018 Apr 12;2018:2021645. doi: 10.1155/2018/2021645. eCollection 2018.

24.

SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia.

Sarno J, Savino AM, Buracchi C, Palmi C, Pinto S, Bugarin C, Jager A, Bresolin S, Barber RC, Silvestri D, Israeli S, Dyer MJS, Cazzaniga G, Nolan GP, Biondi A, Davis KL, Gaipa G.

Oncotarget. 2018 May 1;9(33):22872-22885. doi: 10.18632/oncotarget.25089. eCollection 2018 May 1.

25.

Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men.

Burger EA, Dyer MA, Sy S, Palefsky JM, de Pokomandy A, Coutlee F, Silverberg MJ, Kim JJ.

J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):10-19. doi: 10.1097/QAI.0000000000001727.

PMID:
29757775
26.

A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy.

Trnĕný M, Verhoef G, Dyer MJ, Ben Yehuda D, Patti C, Canales M, Lopez A, Awan FT, Montgomery PG, Janikova A, Barbui AM, Sulek K, Terol MJ, Radford J, Guidetti A, Di Nicola M, Siraudin L, Hatteville L, Schwab S, Oprea C, Gianni AM.

Haematologica. 2018 Aug;103(8):1351-1358. doi: 10.3324/haematol.2017.168401. Epub 2018 May 10.

27.

Rapid visual perception of interracial crowds: Racial category learning from emotional segregation.

Lamer SA, Sweeny TD, Dyer ML, Weisbuch M.

J Exp Psychol Gen. 2018 May;147(5):683-701. doi: 10.1037/xge0000443.

PMID:
29745711
28.

S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth.

Casara P, Davidson J, Claperon A, Le Toumelin-Braizat G, Vogler M, Bruno A, Chanrion M, Lysiak-Auvity G, Le Diguarher T, Starck JB, Chen I, Whitehead N, Graham C, Matassova N, Dokurno P, Pedder C, Wang Y, Qiu S, Girard AM, Schneider E, Gravé F, Studeny A, Guasconi G, Rocchetti F, Maïga S, Henlin JM, Colland F, Kraus-Berthier L, Le Gouill S, Dyer MJS, Hubbard R, Wood M, Amiot M, Cohen GM, Hickman JA, Morris E, Murray J, Geneste O.

Oncotarget. 2018 Apr 13;9(28):20075-20088. doi: 10.18632/oncotarget.24744. eCollection 2018 Apr 13.

29.

Comments on Cost-Effectiveness of Osimertinib for EGFR Mutation-Positive Non-Small-Cell Lung Cancer after Progression during First-Line EGFR Tyrosine Kinase Inhibitor Therapy.

Hoyle C, Dyer M.

J Thorac Oncol. 2018 May;13(5):e83-e84. doi: 10.1016/j.jtho.2018.02.006. No abstract available.

PMID:
29703545
30.

Responses to the Selective Bruton's Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines.

Kozaki R, Vogler M, Walter HS, Jayne S, Dinsdale D, Siebert R, Dyer MJS, Yoshizawa T.

Cancers (Basel). 2018 Apr 23;10(4). pii: E127. doi: 10.3390/cancers10040127.

31.

Differential activation of pro-survival pathways in response to CD40LG/IL4 stimulation in chronic lymphocytic leukaemia cells.

Chen Y, Peubez C, Jayne S, Kocsis-Fodor G, Dyer MJS, Macip S.

Br J Haematol. 2019 Mar;184(5):867-869. doi: 10.1111/bjh.15197. Epub 2018 Apr 20. No abstract available.

PMID:
29676456
32.

Intravenous administration of synthetic platelets (SynthoPlate) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis.

Dyer MR, Hickman D, Luc N, Haldeman S, Loughran P, Pawlowski C, Sen Gupta A, Neal MD.

J Trauma Acute Care Surg. 2018 Jun;84(6):917-923. doi: 10.1097/TA.0000000000001893.

PMID:
29538234
33.

Retinal Cell Type DNA Methylation and Histone Modifications Predict Reprogramming Efficiency and Retinogenesis in 3D Organoid Cultures.

Wang L, Hiler D, Xu B, AlDiri I, Chen X, Zhou X, Griffiths L, Valentine M, Shirinifard A, Sablauer A, Thiagarajan S, Barabas ME, Zhang J, Johnson D, Frase S, Dyer MA.

Cell Rep. 2018 Mar 6;22(10):2601-2614. doi: 10.1016/j.celrep.2018.01.075.

34.

Intravenous synthetic platelet (SynthoPlate) nanoconstructs reduce bleeding and improve 'golden hour' survival in a porcine model of traumatic arterial hemorrhage.

Hickman DA, Pawlowski CL, Shevitz A, Luc NF, Kim A, Girish A, Marks J, Ganjoo S, Huang S, Niedoba E, Sekhon UDS, Sun M, Dyer M, Neal MD, Kashyap VS, Sen Gupta A.

Sci Rep. 2018 Feb 15;8(1):3118. doi: 10.1038/s41598-018-21384-z.

35.

Deep vein thrombosis in mice is regulated by platelet HMGB1 through release of neutrophil-extracellular traps and DNA.

Dyer MR, Chen Q, Haldeman S, Yazdani H, Hoffman R, Loughran P, Tsung A, Zuckerbraun BS, Simmons RL, Neal MD.

Sci Rep. 2018 Feb 1;8(1):2068. doi: 10.1038/s41598-018-20479-x.

36.

The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma.

Nguyen R, Houston J, Chan WK, Finkelstein D, Dyer MA.

Cancer Immunol Immunother. 2018 Apr;67(4):615-626. doi: 10.1007/s00262-017-2108-6. Epub 2018 Jan 11.

PMID:
29327110
37.

The SWI/SNF subunit Bcl7a contributes to motor coordination and Purkinje cell function.

Wischhof L, Maida S, Piazzesi A, Gioran A, Barragan Sanz K, Irsen S, Beyer M, Schultze JL, Dyer MJ, Salomoni P, Ehninger D, Nicotera P, Bano D.

Sci Rep. 2017 Dec 6;7(1):17055. doi: 10.1038/s41598-017-17284-3.

38.

Enforced expression of MIR142, a target of chromosome translocation in human B-cell tumors, results in B-cell depletion.

Kuriyama K, Enomoto Y, Suzuki R, Watanuki J, Hosoi H, Yamashita Y, Murata S, Mushino T, Tamura S, Hanaoka N, Dyer M, Siebert R, Kiyonari H, Nakakuma H, Kitamura T, Sonoki T.

Int J Hematol. 2018 Mar;107(3):345-354. doi: 10.1007/s12185-017-2360-8. Epub 2017 Oct 25.

PMID:
29071477
39.

Stable and ordered amide frameworks synthesised under reversible conditions which facilitate error checking.

Stewart D, Antypov D, Dyer MS, Pitcher MJ, Katsoulidis AP, Chater PA, Blanc F, Rosseinsky MJ.

Nat Commun. 2017 Oct 24;8(1):1102. doi: 10.1038/s41467-017-01423-5.

40.

Bi4O4Cu1.7Se2.7Cl0.3: Intergrowth of BiOCuSe and Bi2O2Se Stabilized by the Addition of a Third Anion.

Gibson QD, Dyer MS, Whitehead GFS, Alaria J, Pitcher MJ, Edwards HJ, Claridge JB, Zanella M, Dawson K, Manning TD, Dhanak VR, Rosseinsky MJ.

J Am Chem Soc. 2017 Nov 8;139(44):15568-15571. doi: 10.1021/jacs.7b06168. Epub 2017 Oct 25.

PMID:
29037045
41.

Relationships between the second to fourth digit ratio (2D:4D) and game-related statistics in semi-professional female basketball players.

Dyer M, Short SE, Short M, Manning JT, Tomkinson GR.

Am J Hum Biol. 2018 Jan;30(1). doi: 10.1002/ajhb.23070. Epub 2017 Oct 12.

PMID:
29024156
42.

Cost-effectiveness of osimertinib in the UK for advanced EGFR-T790M non-small cell lung cancer.

Bertranou E, Bodnar C, Dansk V, Greystoke A, Large S, Dyer M.

J Med Econ. 2018 Feb;21(2):113-121. doi: 10.1080/13696998.2017.1377718. Epub 2017 Sep 21.

PMID:
28880737
43.

The neoepitope landscape in pediatric cancers.

Chang TC, Carter RA, Li Y, Li Y, Wang H, Edmonson MN, Chen X, Arnold P, Geiger TL, Wu G, Peng J, Dyer M, Downing JR, Green DR, Thomas PG, Zhang J.

Genome Med. 2017 Aug 31;9(1):78. doi: 10.1186/s13073-017-0468-3.

44.

Orthotopic patient-derived xenografts of paediatric solid tumours.

Stewart E, Federico SM, Chen X, Shelat AA, Bradley C, Gordon B, Karlstrom A, Twarog NR, Clay MR, Bahrami A, Freeman BB 3rd, Xu B, Zhou X, Wu J, Honnell V, Ocarz M, Blankenship K, Dapper J, Mardis ER, Wilson RK, Downing J, Zhang J, Easton J, Pappo A, Dyer MA.

Nature. 2017 Sep 7;549(7670):96-100. doi: 10.1038/nature23647. Epub 2017 Aug 30.

45.

Paradoxical activation of alternative pro-survival pathways determines resistance to MEK inhibitors in chronic lymphocytic leukaemia.

Chen Y, Germano S, Shelmani G, Kluczna D, Jayne S, Dyer MJS, Macip S.

Br J Haematol. 2018 Sep;182(6):921-924. doi: 10.1111/bjh.14880. Epub 2017 Aug 2. No abstract available.

PMID:
28771685
46.

Hsp72 and Nek6 Cooperate to Cluster Amplified Centrosomes in Cancer Cells.

Sampson J, O'Regan L, Dyer MJS, Bayliss R, Fry AM.

Cancer Res. 2017 Sep 15;77(18):4785-4796. doi: 10.1158/0008-5472.CAN-16-3233. Epub 2017 Jul 18.

47.

Redox-controlled potassium intercalation into two polyaromatic hydrocarbon solids.

Romero FD, Pitcher MJ, Hiley CI, Whitehead GFS, Kar S, Ganin AY, Antypov D, Collins C, Dyer MS, Klupp G, Colman RH, Prassides K, Rosseinsky MJ.

Nat Chem. 2017 Jul;9(7):644-652. doi: 10.1038/nchem.2765. Epub 2017 Apr 24.

PMID:
28644481
48.

A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma.

Pratt G, Yap C, Oldreive C, Slade D, Bishop R, Griffiths M, Dyer MJS, Fegan C, Oscier D, Pettitt A, Matutes E, Devereux S, Allsup D, Bloor A, Hillmen P, Follows G, Rule S, Moss P, Stankovic T.

Br J Haematol. 2017 Jun 23. doi: 10.1111/bjh.14793. [Epub ahead of print] No abstract available.

PMID:
28643365
49.

Accelerated discovery of two crystal structure types in a complex inorganic phase field.

Collins C, Dyer MS, Pitcher MJ, Whitehead GFS, Zanella M, Mandal P, Claridge JB, Darling GR, Rosseinsky MJ.

Nature. 2017 Jun 7;546(7657):280-284. doi: 10.1038/nature22374.

PMID:
28593963
50.

Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring.

Dyer M, Haldeman S, Gutierrez A, Kohut L, Sen Gupta A, Neal MD.

J Vis Exp. 2017 May 21;(123). doi: 10.3791/55554.

Supplemental Content

Support Center